The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

According to BCC Research, AI is speeding up clinical development with smarter recruitment, better analytics, and real-time ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

The new rules introduce a fast-track notification route, enabling quicker starts for lower-risk trials and maintaining safety ...

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell BrightPath Bio (Tokyo Stock Exchange Growth ...

Dodd indicated, "We anticipate having vaccine available for clinical evaluation early next year," referencing GEO-MVA. Further, "Our priorities and anticipated milestones for 2025 through 2026 remain ...